Arsonoliposomes for the potential treatment of medulloblastoma

Pharmaceutical Research

Volumn 26, Issue 10, 2009, Pages 2237-2246

  Favretto, Marco E ^a   Marouf, Showan ^b   Ioannou, Panagiotis ^c   Antimisiaris, Sophia G ^c   Parker, Terence L ^b   Kallinteri, Paraskevi ^a  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Apoptosis; Arsonoliposomes; Cellular uptake; Liposomes; Medulloblastoma

Indexed keywords

ARSONOLIPOSOME; CHLORPROMAZINE; CHOLESTEROL; CLATHRIN; DISTEAROYLPHOSPHATIDYLCHOLINE; FILIPIN; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CAVEOLA; CELL STRAIN 3T3; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOCYTOBIOSIS; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME; TUMOR CELL;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; ARSENICALS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; LIPOSOMES; MEDULLOBLASTOMA; MICE; TREATMENT OUTCOME;

EID: 69949144283     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9940-0     Document Type: Article

References (24)

1. RJ Gilbertson 2004 Medulloblastoma: signalling a change in treatment Lancet Oncol 5 209 18
2. L Cervoni A Maleci M Salvati R Delfini G Cantore 1994 Medulloblastoma in late adults: report of two cases and critical review of the literature J Neurooncol 19 169 73
3. C Raffel 2004 Medulloblastoma: molecular genetics and animal models Neoplasia 6 310 22
4. MA Castello A Clerico G Deb C Dominici P Fidani A Donfrancesco 1990 High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors Am J Pediatr Hematol Oncol 12 297 300 (Pubitemid 20323427)
5. D Schuler P SomLo R Kooos R Kalmanchey E Paraicz 1992 Treatment of malignant scala posterior brain tumors in children: the chemotherapy of relapsed medulloblastoma with a dibromdulcitol containing drug regime and pharmacokinetic studies of dibromdulcitol in children Med Pediatr Oncol 20 312 4
6. JD Borsi C Csaki T Ferencz W Oster 1996 Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin Anticancer Drugs 7 121 6
7. D Fatouros O Gortzi P Klepetsanis SG Antimisiaris MC Stuart A Brisson, et al. 2001 Preparation and properties of arsonolipid containing liposomes Chem Phys Lipids 109 75 89
8. O Gortzi E Papadimitriou CG Kontoyannis SG Antimisiaris PV Ioannou 2002 Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture Pharm Res 19 79 86 (Pubitemid 34075110)
9. O Gortzi SG Antimisiaris P Klepetsanis E Papadimitriou PV Ioannou 2003 Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture Eur J Pharm Sci 18 175 83
10. J Rejman V Oberle IS Zuhorn D Hoekstra 2004 Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem J 377 159 69
11. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63
12. W Meng TL Parker P Kallinteri DA Walker S Higgins GA Hutcheon, et al. 2006 Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in DAOY monolayer J Control Release 116 314 21
13. LH Wang KG Rothberg RG Anderson 1993 Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J Cell Biol 123 1107 17
14. US Huth R Schubert R Peschka-Suss 2006 Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging J Control Release 110 490 504
15. M Gumbleton AG Abulrob L Campbell 2000 Caveolae: an alternative membrane transport compartment Pharm Res 17 1035 48
16. SB Sieczkarski GR Whittaker 2002 Dissecting virus entry via endocytosis J Gen Virol 83 1535 45
17. J Dai RS Weinberg S Waxman Y Jing 1999 Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system Blood 93 268 77
18. MN Haikou P Zagana PV Ioannou SG Antimisiaris 2006 Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione J Nanosci Nanotechnol 6 2974 8
19. AM Evens MS Tallman RB Gartenhaus 2004 The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future Leuk Res 28 891 900
20. J Zhu MH Koken F Quignon MK Chelbi-Alix L Degos ZY Wang, et al. 1997 Arsenic-induced PmL targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia Proc Natl Acad Sci USA 94 3978 83
21. ZG Wang R Rivi L Delva A Konig DA Scheinberg C Gambacorti-Passerini, et al. 1998 Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PmL and PmL-RARalpha independent manner Blood 92 1497 504
22. M van Engeland LJ Nieland FC Ramaekers B Schutte CP Reutelingsperger 1998 Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure Cytometry 31 1 9
23. HA Andree CP Reutelingsperger R Hauptmann HC Hemker WT Hermens GM Willems 1990 Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers J Biol Chem 265 4923 8
24. D Timotheatou PV Ioannou A Scozzafava F Briganti CT Supuran 1996 Carbonic anhydrase interaction with lipothioars enites: a novel class of isozymes I and II inhibitors Met Based Drugs 3 263 8